ABBOTT LABORATORIES (NYSE:ABT) Files An 8-K Other Events

ME Staff
-
0

ABBOTT LABORATORIES (NYSE:ABT) Files An 8-K Other Events

Item 8.01. Other Events.

On April26, 2016, Abbott Laboratories (the Company) announced
that it had entered into a definitive Agreement and Plan of
Merger with St. Jude Medical,Inc., a Delaware corporation (St.
Jude Medical), Vault Merger Sub,Inc., a Delaware corporation and
wholly owned subsidiary of the Company, and Vault Merger Sub,
LLC, a Delaware limited liability company and wholly owned
subsidiary of the Company, providing for the acquisition of St.
Jude Medical by the Company.

The consolidated balance sheets of St. Jude Medical and
subsidiaries as of January2, 2016 and January3, 2015 and the
related consolidated statements of earnings, comprehensive
income, shareholders equity and cash flows for the years ended
January2, 2016,January3, 2015 and December28, 2013 and the notes
related thereto contemplated by Rule3-05 of Regulation S-X are
attached hereto as Exhibit99.1 and are incorporated herein by
reference.

The condensed consolidated balance sheets of St. Jude Medical and
subsidiaries as of October1, 2016 and January2, 2016, and the
related condensed consolidated statements of earnings,
comprehensive income and cash flows for the nine months ended
October1, 2016 and October3, 2015 and the notes related thereto
contemplated by Rule3-05 of Regulation S-X are attached hereto as
Exhibit99.2 and are incorporated here in by reference.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibits.

ExhibitNo.

Description

Exhibit23.1

Consent of Ernst Young LLP,Independent Registered Public
Accounting Firm.

Exhibit23.2

Consent of Ernst Young LLP,Independent Registered Public
Accounting Firm.

Exhibit23.3

Consent of Deloitte Touche LLP,Independent Registered
Public Accounting Firm.

99.1

Financial Statements of Businesses Acquired

(i)Report of Independent Registered Public Accounting Firm

(ii)Consolidated balance sheets of St. Jude Medical and
subsidiaries as of January2, 2016 and January3, 2015 and
the related consolidated statements of earnings,
comprehensive income, shareholders equity and cash flows
for the years ended January2, 2016, January3, 2015 and
December28, 2013 and the notes related thereto

99.2

Financial Statements of Businesses Acquired

(i)Condensed consolidated balance sheets of St. Jude
Medical and subsidiaries as of October1, 2016 and January2,
2016, and the related condensed consolidated statements of
earnings, comprehensive income and cash flows for the nine
months ended October1, 2016 and October3, 2015 and the
notes related thereto



About ABBOTT LABORATORIES (NYSE:ABT)

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Nutrition Products segment includes the sales of a line of adult and pediatric nutritional products. The Diagnostic Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.

ABBOTT LABORATORIES (NYSE:ABT) Recent Trading Information

ABBOTT LABORATORIES (NYSE:ABT) closed its last trading session up +0.43 at 40.38 with 8,890,514 shares trading hands.